Glasgow pharmatech start-up backed by Scottish Enterprise
Glasgow-based Neuvior Pharmaceuticals has secured £99,000 in funding from Scottish Enterprise.
The money will support a nine-month feasibility study exploring how PHARMORIS, its artificial intelligence-enabled technology can help the NHS identify, assess and deploy generic medicines.
Neuvior supports governed pharmaceutical intelligence infrastructure, turning medicines data into measurable value across healthcare systems. The SMART: SCOTLAND project will test whether PHARMORIS can help close that gap by developing AI-supported... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
